SYNV-cyclo (CGGYF)
SYNV-cyclo (CGGYF) is a Staphylococcus hominis (S. hominis) C5 autoinducing peptide. SYNV-cyclo (CGGYF) inhibits S. aureus activity. SYNV-cyclo (CGGYF) has the potential for the research of S. aureus-mediated epithelial damage and inflammation[1].
Product Specifications
UNSPSC
12352209
Target
Bacterial
Type
Peptides
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/synv-cyclo-cggyf.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](N)CO)N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(NCC(N[C@H](C(N[C@H]1CC2=CC=CC=C2)=O)CC3=CC=C(O)C=C3)=O)=O)=O)CSC1=O)=O)C(C)C)=O)CC(N)=O)=O)CC4=CC=C(O)C=C4
Molecular Formula
C46H58N10O13S
Molecular Weight
991.08
References & Citations
[1]Williams MR, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med. 2019 May 1;11 (490) :eaat8329.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402265-500 1x 500 µL
BCL2-like 2 (CPTC-BCL2L2-2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 